Jon T. Holmlund

Biography

Dr. Holmlund is a medical oncologist who has served Galera as Chief Medical Officer since October 2012. He has over 25 years’ experience in oncology drug development, in senior positions in industry (CMO of Ascenta Therapeutics, VP of Development at Isis [now Ionis] Pharmaceuticals), as a consultant to large and small biopharmaceutical companies, and as a senior investigator in the National Cancer Institute’s Cancer Therapy Evaluation Program and Biological Response Modifiers Program. He received his MD from SUNY Buffalo and completed postgraduate training in internal medicine and medical oncology at George Washington University Medical Center (Washington, DC).    

Research Interest

Host defense mechanisms,LPS effects on neurotransmitters